Hebei Xingang Pharmaceutical Co., Ltd., commonly referred to as Xingang Pharma, is a prominent player in the pharmaceutical industry, headquartered in Hebei, China. Established in 2000, the company has made significant strides in the development and manufacturing of a diverse range of pharmaceutical products, including active pharmaceutical ingredients (APIs) and finished dosage forms. With a strong operational presence in both domestic and international markets, Xingang Pharma is recognised for its commitment to quality and innovation. The company’s core offerings, which include a variety of generic medications and specialty pharmaceuticals, are distinguished by their adherence to stringent regulatory standards and advanced production techniques. Xingang Pharma has achieved notable milestones, positioning itself as a trusted supplier in the global pharmaceutical landscape, and continues to expand its reach through strategic partnerships and a focus on research and development.
How does Hebei Xingang Pharmaceutical Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Instruments industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Hebei Xingang Pharmaceutical Co., Ltd.'s score of 20 is lower than 94% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Hebei Xingang Pharmaceutical Co., Ltd. currently does not have publicly available carbon emissions data for recent years, as indicated by the absence of specific figures. Consequently, there are no reported emissions in terms of Scope 1, 2, or 3. Despite the lack of detailed emissions data, the company is likely aware of the growing importance of climate commitments within the pharmaceutical industry. Many companies in this sector are increasingly focusing on sustainability and reducing their carbon footprints. While Hebei Xingang Pharmaceutical has not outlined specific reduction targets or initiatives, it is essential for organisations in this field to engage in climate action, potentially aligning with global standards such as the Science Based Targets initiative (SBTi) and participating in climate pledges. As the industry evolves, it is anticipated that Hebei Xingang Pharmaceutical will develop and communicate its climate commitments and reduction strategies to contribute to a more sustainable future.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Hebei Xingang Pharmaceutical Co., Ltd. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.